פרוטלוס 以色列 - 希伯来文 - Ministry of Health

פרוטלוס

mediline ltd. - strontium ranelate 2 g - granules for oral suspension - strontium ranelate - treatment of postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures.

מדיקינט MR כמוסות בשחרור מושהה 20 מ"ג 以色列 - 希伯来文 - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 20 מ"ג

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מודיקיט MR כמוסות בשחרור מושהה 30 מ"ג 以色列 - 希伯来文 - Ministry of Health

מודיקיט mr כמוסות בשחרור מושהה 30 מ"ג

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מדיקינט MR כמוסות בשחרור מושהה 40 מ"ג 以色列 - 希伯来文 - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 40 מ"ג

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

קנקא 以色列 - 希伯来文 - Ministry of Health

קנקא

mediline ltd. - benzocaine 20 % - solution - benzocaine - relief of pain and forms protection coating for ulcers of the mouth and lips.

קרבגלו 以色列 - 希伯来文 - Ministry of Health

קרבגלו

medison pharma ltd - carglumic acid - טבליות ניתנות לפיזור - carglumic acid 200 mg - carglumic acid - carglumic acid - carbaglu is indicated in treatment of :- hyperammonaemia due to n - acetylglutamate synthase primary deficiency.- hyperammonaemia due to isovaleric acidaemia.- hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.

נגלזיים 以色列 - 希伯来文 - Ministry of Health

נגלזיים

medison pharma ltd - galsulfase - תרכיז להכנת תמיסה לאינפוזיה - galsulfase 1 mg/ml - galsulfase - galsulfase - naglazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mpsvi (n-acetylglactosamine 4 sulfatase deficiency maroteaux-lamy syndrome).

נודקסטה 以色列 - 希伯来文 - Ministry of Health

נודקסטה

medison pharma ltd - dextromethorphan hydrobromide; quinidine sulfate - קפסולות - quinidine sulfate 10 mg; dextromethorphan hydrobromide 20 mg - quinidine - quinidine - for the treatment of pseudobulbar affect (pba) in als and ms patients only.

קוראלאן 7.5 מג 以色列 - 希伯来文 - Ministry of Health

קוראלאן 7.5 מג

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 7.5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

קוראלאן 5 מג 以色列 - 希伯来文 - Ministry of Health

קוראלאן 5 מג

medison pharma ltd - ivabradine as hydrochloride - טבליות מצופות פילם - ivabradine as hydrochloride 5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.